HIV-1 peripheral neuropathy and combination antiretroviral therapy

Lancet

Volumn 352, Issue 9144, 1998, Pages 1906-1907

  Markus, R ^a   Brew, B J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

ACTION POTENTIAL; ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOTOR NERVE; NEUROPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORY GANGLION; VIRUS LOAD;

EID: 0032512269     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60397-2     Document Type: Article

References (2)

1. 1 Dalakas MC, Cupler EJ. Neuropathies in HIV-1 infection. Bailliere's Clin Neurol 1996; 5: 199-218.
2. 2 Griffin JW, Wesselingh SL, Griffin DE, Glass JD, McArther JC. Peripheral nerve disorders in HIV infection: similarities and contrasts with central nervous system disorders. In: Price RW, Perry RW, eds. HIV AIDS and the brain. New York: Raven Press, 1994: 159-82.